CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase 1b Safety and Immunogenicity Study of Cytomegalovirus (CMV) Directed Type 1 Polarized Dendritic Cell Vaccination (αDC1) After Allogeneic Hematopoietic Cell Transplantation (alloHCT) for Hematologic Malignancies

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT05589844
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:39:12.228170+00:00
Published At: 2023-04-27T00:00:00+00:00
Record Updated At: 2023-04-27
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Cytomegaloviral Infection", "Hematopoietic and Lymphoid System Neoplasm"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2023-04-27"
protocolSection.identificationModule.nctId: "NCT05589844"
protocolSection.identificationModule.officialTitle: "A Phase 1b Safety and Immunogenicity Study of Cytomegalovirus (CMV) Directed Type 1 Polarized Dendritic Cell Vaccination (\u03b1DC1) After Allogeneic Hematopoietic Cell Transplantation (alloHCT) for Hematologic Malignancies"
protocolSection.statusModule.overallStatus: "WITHDRAWN"
protocolSection.designModule.phases: ["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.